Jafron Biomedical Co.,Ltd. (300529.SZ)
CNY 30.04
(-0.07%)
CNY 30.04
(-0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 916.74 Million | 883.8 Million | 1.24 Billion | 957.48 Million | 583.49 Million | 384.07 Million |
| Net Income | 425.72 Million | 880.91 Million | 1.19 Billion | 872.99 Million | 568.69 Million | 400.94 Million |
| Depreciation & Amortization | 94.79 Million | 73.99 Million | 54.05 Million | 36.72 Million | 29.78 Million | 21.79 Million |
| Deferred income taxes | -1.01 Million | -1.99 Million | -17.22 Million | -2.9 Million | -2.93 Million | -2.93 Million |
| Stock-based compensation | 19.09 Million | -8.73 Million | 7.51 Million | 22.35 Million | 17.12 Million | 11.31 Million |
| Change in working capital | 291.05 Million | -101.98 Million | -302.3 Thousand | 35.99 Million | -1.75 Million | -13.51 Million |
| Other non-cash items | 72.52 Million | 41.6 Million | 9.52 Million | -7.68 Million | -27.43 Million | -25.14 Million |
| Investing Cash Flow | -249.64 Million | -305.9 Million | -670.21 Million | -341.1 Million | -197.12 Million | -254.92 Million |
| Investments in PPE | -247.25 Million | -475.88 Million | -537.41 Million | -357.11 Million | -220.67 Million | -173.52 Million |
| Acquisitions | 12.6 Million | 6.9 Million | 987.3 Thousand | 357.92 Million | -6.27 Million | -28.87 Million |
| Investment purchases | -15 Million | -2.05 Billion | -4.55 Billion | -1.31 Billion | -2.84 Billion | -3.61 Billion |
| Sales/Maturities of investments | - | 2.21 Billion | 4.41 Billion | 1.32 Billion | 2.87 Billion | 3.56 Billion |
| Other Investing Activities | -2.39 Million | -184.02 Thousand | 0.70 | -357.11 Million | 18.8 Thousand | 380.51 |
| Financing Cash Flow | -451.91 Million | -365.93 Million | 165.17 Million | -313.02 Million | -195.44 Million | -114.5 Million |
| Debt repayment | -418.42 Million | -296.31 Million | -998.3 Million | - | - | - |
| Dividends payments | -535.23 Million | -716.98 Million | -531.01 Million | -377.8 Million | -251 Million | -146.15 Million |
| Common Stock Repurchased | -382.58 Million | -5.19 Million | -500.12 Million | -8.28 Million | -5.34 Million | -8.96 Million |
| Common Stock Issuance | - | -291.12 Million | -498.17 Million | - | - | - |
| Other Financing Activities | -308.54 Million | 956.11 Million | 2.69 Billion | 73.06 Million | 60.9 Million | 31.64 Million |
| Accounts receivables | 277.22 Million | -7.9 Million | -110.41 Million | -83.4 Million | -34.22 Million | -39.51 Million |
| Accounts payables | 52.14 Million | 60.65 Million | 203.26 Million | 150.59 Million | 66.61 Million | 44.8 Million |
| Inventory | -37.29 Million | -152.74 Million | -75.93 Million | -28.28 Million | -31.2 Million | -15.87 Million |
| Other working capital | 19.09 Million | -1.99 Million | -17.22 Million | -2.9 Million | -2.93 Million | 2.35 Million |
| Cash at beginning of period | 2.52 Billion | 2.31 Billion | 1.57 Billion | 1.26 Billion | 1.07 Billion | 1.06 Billion |
| Cash at end of period | 2.74 Billion | 2.52 Billion | 2.31 Billion | 1.57 Billion | 1.26 Billion | 1.07 Billion |
| Capital Expenditure | -247.25 Million | -475.88 Million | -537.41 Million | -357.11 Million | -220.67 Million | -173.52 Million |
| Effect of forex changes on cash | 11.39 Thousand | -36.39 Thousand | -4.81 | -35.5 Thousand | -540.93 | 4156.13 |
| Net cash flow / Change in cash | 215.19 Million | 211.92 Million | 744.36 Million | 303.31 Million | 190.92 Million | 14.64 Million |
| Free Cash Flow | 669.49 Million | 407.91 Million | 712 Million | 600.37 Million | 362.82 Million | 210.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 239.12 Million | 267.73 Million | 284.76 Million | 12.83 Million | 425.72 Million | 146.14 Million |
| Depreciation & Amortization | - | 33.54 Million | 33.54 Million | 31.04 Million | 94.79 Million | -44.82 Million |
| Deferred income taxes | - | - | - | - | -1.01 Million | 135.43 Million |
| Stock-based compensation | - | 18.3 Million | - | 19.09 Million | 19.09 Million | -8.35 Million |
| Change in working capital | - | 58.39 Million | - | 259.02 Million | 291.05 Million | -79.36 Million |
| Other non-cash items | -100.5 Million | 13.62 Million | 224.85 Million | 351.39 Million | 72.52 Million | 4.3 Million |
| Investing Cash Flow | -1.06 Billion | -281.73 Million | -841.79 Million | -160.7 Million | -249.64 Million | -25.67 Million |
| Investments in PPE | -51.37 Million | -32.23 Million | -95.86 Million | -146.29 Million | -247.25 Million | -28.42 Million |
| Acquisitions | 4.81 Million | 800.00 | 69.02 Thousand | 583.3 Thousand | 12.6 Million | 2.74 Million |
| Investment purchases | -1.54 Billion | -857.5 Million | -1.16 Billion | -15 Million | -15 Million | - |
| Sales/Maturities of investments | 531.36 Million | 608 Million | 422 Million | - | - | - |
| Other Investing Activities | 4.81 Million | -243.84 Million | -743.4 Million | -14.41 Million | -2.39 Million | 0.50 |
| Financing Cash Flow | -81.35 Million | -553.12 Million | -93.2 Million | -112.93 Million | -451.91 Million | -104.24 Million |
| Debt repayment | -77.13 Million | -117.92 Million | -125.32 Million | -56.77 Million | -418.42 Million | -259.58 Million |
| Dividends payments | -4.22 Million | -324.91 Million | -5.53 Million | -3.84 Million | -535.23 Million | -6.95 Million |
| Common Stock Repurchased | 371.27 Million | -371.27 Million | - | -382.58 Million | -382.58 Million | 5.73 Million |
| Common Stock Issuance | - | - | - | - | - | -5.73 Million |
| Other Financing Activities | - | -61.91 Million | -218.53 Million | -52.31 Million | -308.54 Million | 162.29 Million |
| Accounts receivables | - | -25.77 Million | - | 277.22 Million | 277.22 Million | -92.89 Million |
| Accounts payables | - | - | - | - | 52.14 Million | 8.35 Million |
| Inventory | - | 64.91 Million | - | -37.29 Million | -37.29 Million | 13.52 Million |
| Other working capital | - | 19.24 Million | - | 19.09 Million | 19.09 Million | -8.35 Million |
| Cash at beginning of period | 1.72 Billion | 2.39 Billion | 2.7 Billion | 2.68 Billion | 2.52 Billion | 2.66 Billion |
| Cash at end of period | 706.91 Million | 1.74 Billion | 2.39 Billion | 2.74 Billion | 2.74 Billion | 2.68 Billion |
| Capital Expenditure | -51.37 Million | -32.23 Million | -95.86 Million | -146.29 Million | -247.25 Million | -28.42 Million |
| Effect of forex changes on cash | -883.44 Thousand | 144.59 Thousand | -48.87 Thousand | 29.94 Thousand | 11.39 Thousand | 10.58 Thousand |
| Net cash flow / Change in cash | -1.02 Billion | -642.95 Million | -311.28 Million | 53.09 Million | 215.19 Million | 23.43 Million |
| Free Cash Flow | 87.24 Million | 215.58 Million | 413.75 Million | 186.89 Million | 669.49 Million | 124.92 Million |
2449
RADIANTCMS
SNWS
000498
HTRC
SMIFS